If this was a newspaper and not a nice shiny website plugged into the wall with a few blue cables coming out the back, then ...

Tariffs, executive orders, and FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's actions are pressuring a historically "safe" sector.

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

Roiling headlines in the last couple of years were the bankruptcy filings of the corporations Purdue Pharma and the national organization of Boy Scouts of America (now called Scouting America).

The voluble billionaire discusses his mission to transform health care, why Kamala lost, the problem with Bluesky, and much ...

Most recently, an effort to reduce drug prices in the US to match international pricing has frustrated Big Pharma executives ... benefits managers (PBMs), which Trump called "middle men" and accused ...

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, one biotech CEO said.

Kingmaker is an ambitious return to form, with Xzibit fully embracing his veteran status in the hopes of spreading some knowledge. Songs like opener “Play This At My Funeral” aim to inspire the youth, ...

Steve Bannon, architect of US president Donald Trump’s America First movement, spoke to Edward Luce, US national editor, at the FTWeekend festival in Washington DC. The populist nationalist shared his ...

Currently, more than 300 million people are diagnosed with hepatitis around the world, according to the World Hepatitis ...

At the national level, the NCPA coordinates with other Big Pharma-funded groups, notably Pharmacists United for Truth and Transparency and the American Pharmacists Association, to promote PBM ...